Crowley John J
Insider CIK 1587972 · CRL SVP, Chief Accounting Officer · FUSN Chief Financial Officer · CNTA Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 600,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 250,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 181,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer | 2026-06-24 | 2026-06-24 | 45,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2026-02-02 | 2026-02-03 | 181,000 | — | $0 | 181,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award | 2026-02-02 | 2026-02-03 | 45,000 | — | $0 | 45,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2025-02-03 | 2025-02-04 | 250,000 | — | $0 | 250,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2024-07-01 | 2024-07-02 | 600,000 | — | $0 | 600,000 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer deriv | 2024-06-04 | 2024-06-04 | 167,000 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer deriv | 2024-06-04 | 2024-06-04 | 313,359 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer deriv | 2024-06-04 | 2024-06-04 | 106,100 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer deriv | 2024-06-04 | 2024-06-04 | 250,000 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer deriv | 2024-06-04 | 2024-06-04 | 63,700 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer deriv | 2024-06-04 | 2024-06-04 | 138,000 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer deriv | 2024-06-04 | 2024-06-04 | 60,852 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer deriv | 2024-06-04 | 2024-06-04 | 26,972 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer deriv | 2024-06-04 | 2024-06-04 | 38,561 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | D To issuer | 2024-06-04 | 2024-06-04 | 10,410 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | A Award deriv | 2024-01-04 | 2024-01-05 | 63,700 | — | $0 | 63,700 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | A Award deriv | 2024-01-04 | 2024-01-05 | 106,100 | — | $0 | 106,100 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | A Award deriv | 2023-01-05 | 2023-01-09 | 250,000 | — | $0 | 250,000 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | A Award deriv | 2022-02-01 | 2022-02-03 | 167,000 | — | $0 | 167,000 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | A Award | 2021-08-31 | 2022-02-03 | 3,910 | — | $0 | 10,410 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | A Award deriv | 2021-02-04 | 2021-02-08 | 138,000 | — | $0 | 138,000 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | P Buy | 2020-06-30 | 2020-07-02 | 6,500 | $17.00 | $110.5K | 6,500 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | A Award deriv | 2020-06-25 | 2020-06-30 | 60,852 | — | $0 | 60,852 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | A Award deriv | 2020-06-25 | 2020-06-30 | 26,972 | — | $0 | 26,972 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | A Award deriv | 2020-02-06 | 2020-06-30 | 38,561 | — | $0 | 38,561 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | F Tax w/h | 2016-10-01 | 2016-10-04 | 284 | $83.34 | $23.7K | 5,599 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | M Exercise deriv | 2016-05-24 | 2016-05-25 | 913 | — | $0 | 1,825 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | M Exercise deriv | 2016-05-24 | 2016-05-25 | 1,000 | — | $0 | 2,000 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | S Sale | 2016-05-24 | 2016-05-25 | 1,913 | $85.00 | $162.6K | 5,883 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | M Exercise | 2016-05-24 | 2016-05-25 | 913 | $59.41 | $54.2K | 7,796 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | M Exercise | 2016-05-24 | 2016-05-25 | 1,000 | $46.62 | $46.6K | 6,883 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | F Tax w/h | 2016-02-28 | 2016-03-01 | 76 | $73.70 | $5.6K | 5,883 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | F Tax w/h | 2016-02-27 | 2016-03-01 | 68 | $73.70 | $5.0K | 5,959 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award deriv | 2016-02-26 | 2016-03-01 | 5,360 | — | $0 | 5,360 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2016-02-26 | 2016-03-01 | 1,093 | — | $0 | 6,027 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | F Tax w/h | 2015-10-01 | 2015-10-02 | 285 | $63.52 | $18.1K | 4,934 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | M Exercise deriv | 2015-03-04 | 2015-03-06 | 912 | — | $0 | 2,738 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | M Exercise | 2015-03-04 | 2015-03-06 | 912 | $59.41 | $54.2K | 6,131 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | S Sale | 2015-03-04 | 2015-03-06 | 100 | $76.52 | $7.7K | 6,031 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | S Sale | 2015-03-04 | 2015-03-06 | 300 | $76.52 | $23.0K | 5,731 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | S Sale | 2015-03-04 | 2015-03-06 | 100 | $76.53 | $7.7K | 5,219 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | S Sale | 2015-03-04 | 2015-03-06 | 412 | $76.53 | $31.5K | 5,319 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | F Tax w/h | 2015-02-28 | 2015-03-02 | 227 | $76.67 | $17.4K | 5,219 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award deriv | 2015-02-27 | 2015-03-02 | 3,699 | — | $0 | 3,699 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2015-02-27 | 2015-03-02 | 839 | — | $0 | 5,446 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | M Exercise deriv | 2014-11-04 | 2014-11-05 | 1,000 | — | $0 | 3,000 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | S Sale | 2014-11-04 | 2014-11-05 | 900 | $64.00 | $57.6K | 4,707 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | M Exercise | 2014-11-04 | 2014-11-05 | 1,000 | $46.62 | $46.6K | 5,607 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | S Sale | 2014-11-04 | 2014-11-05 | 100 | $64.01 | $6.4K | 4,607 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | F Tax w/h | 2014-10-01 | 2014-10-02 | 286 | $59.74 | $17.1K | 4,607 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award deriv | 2014-02-28 | 2014-03-04 | 3,650 | $59.41 | $216.8K | 3,650 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2014-02-28 | 2014-03-04 | 1,393 | — | $0 | 4,893 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award deriv | 2013-10-01 | 2013-10-03 | 4,000 | — | $0 | 4,000 | SEC↗ |
| CRL CHARLES RIVER LABORATORIES | A Award | 2013-10-01 | 2013-10-03 | 3,500 | — | $0 | 3,500 | SEC↗ |